Format

Send to

Choose Destination
Eur Respir J. 2018 Jan 31;51(2). pii: 1702082. doi: 10.1183/13993003.02082-2017. Print 2018 Feb.

Mindfulness-based cognitive therapy in COPD: a cluster randomised controlled trial.

Author information

1
Unit for Psychooncology and Health Psychology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ifarver@psy.au.dk.
2
Unit for Psychooncology and Health Psychology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.
3
Dept of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.
4
Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.
5
Dept of Psychology, University of Cambridge, Cambridge, UK.
6
Centre for Self Management Support, Addenbrooke's Hospital, Cambridge, UK.

Abstract

A considerable proportion of patients with chronic obstructive pulmonary disease (COPD) entering pulmonary rehabilitation (PR) report psychological distress, which is often accompanied by poor physical health status. Mindfulness-based cognitive therapy (MBCT) has been shown to improve psychological and physical outcomes in other chronic diseases. We therefore evaluated the efficacy of MBCT as an add-on to a standard PR programme in COPD.COPD patients eligible for PR were cluster randomised to receive either an 8-week, group-based MBCT programme as an add-on to an 8-week PR programme (n=39), or PR alone (n=45). The primary outcomes of psychological distress and physical health status impairment were measured with the Hospital Anxiety and Depression Scale (HADS) and the COPD Assessment Test (CAT) before randomisation (T1), mid- (T2) and post-intervention (T3), and at 3 (T4) and 6 (T5) months' follow-up .A statistically significant time×arm effect was found for the HADS (Cohen's d=0.62, 95% CIs (d)=0.18-1.06, p=0.010). The treatment effect on the CAT failed to reach statistical significance (d=0.42, 95% CIs (d)=-0.06-0.90, p=0.061).MBCT showed a statistically significant and durable effect on psychological distress, indicating that MBCT may be an efficacious add-on to standard PR programmes in COPD.

TRIAL REGISTRATION:

ClinicalTrials.gov NCT02042976.

Conflict of interest statement

Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center